Winter Symposium 2023 Panelists
AI Panel
Manish Chhadua
Technologist & Founding Partner
ReUnite Rx / Cloud Rx
Manish Chhadua began his professional journey in software and spent 15 years at Verizon, developing products and solutions for enterprise customers. Leveraging his extensive experience in business and software, Manish transitioned into entrepreneurship, founding multiple companies that synergize his skills with the fertility sector. As the managing partner of ReUnite Rx, one of the largest fertility medication management programs in the United States, Manish plays a pivotal role. His academic background includes a Computer Science degree from the University of Texas at Austin.
Dr. Mia Chorney, DNP, FNP-BC.
HonorHealth Women’s Heart Health Center
Mia Chorney, from HonorHealth works in a leadership role at the Women’s Heart Center. Mia is currently leading the prescreening of Artificial Intelligence Cardiac Digital Health Information Assistant as the 1st site in the USA. She is works in cardiology; however, is Certified in Artificial Intelligence in Healthcare and AI in Business Strategy. She is a seed/preseries A Funding Investor in a Visual AI company, and currently Co-Founder of a new start up of women’s health evidence-based menopause application incorporating wearable technology, avatar identification, health daily recommendations to work on risk reduction and improve quality of life.
Erez Druk
Co-founder and CEO
Getfreed.ai
Hi, my name is Erez and I'm married to Gabi, a primary care provider. I met Gabi when she started medical school and found that the only thing she said more than "I love you" was "I have notes to do." That's why I created Freed -- to free clinicians (wife included) from the burden of charting. Ironically, Freed became popular and now I spend more time with Freed than with Gabi.
You can try Freed for free at getfreed.ai. If you like it, use this $50 discount code at checkout: OBGYNAI.
Paxton Maeder-York
CEO & Founder
Alife Health
Paxton Maeder-York is the CEO and founder of Alife Health, a fertility technology company building artificial intelligence tools to advance in-vitro fertilization (IVF). Previously, Paxton was the first clinical engineer and the first product manager at Auris Health (acquired by Johnson & Johnson for $3.4 Billion), where he helped develop a surgical robotics platform to detect and treat early stage lung cancer. Paxton founded Alife Health in 2020 with the mission of building a modern operating system for IVF, powered by artificial intelligence. Alife Health’s technology empowers physicians and patients to make the best clinical decisions possible through advanced analytics delivered in an optimally designed, medical-grade software ecosystem. Paxton received his B.S. in Biomedical Engineering, M.S. in Computational Science, and MBA from Harvard University. Alife is based in San Francisco and backed by top tier venture capital investors including Lux Capital, Maveron, and Union Square Ventures. To learn more visit www.alifehealth.com.
Private Equity Panel
Joshua Griffin
Principal
Webster Equity Partners
Joshua Griffin joined Webster Equity Partners as a senior associate in 2021. Prior to joining Webster, he was a vice president at Greenhill & Co., where he advised healthcare clients on a range of buy-side and sell-side transactions. Prior to joining Greenhill, Griffin worked at Cain Brothers, where he advised middle-market healthcare companies on a range of M&A-related engagements.
Griffin was educated at Temple University and NYU Stern School of Business.
Mitchell S. Stern
Managing Director, Head of Healthcare
Dresner Partners
Mr. Stern is Managing Director and Head of Dresner’s Healthcare Group, specializing in Mergers & Acquisitions. Prior to Dresner Partners, Mr. Stern worked at Morgan Joseph, SMH Capital, Glocap Advisors, Needham, Schroders and Salomon Brothers. Mr. Stern also worked in M&A at Deloitte & Touche and as a CPA with Ernst & Young. Mr. Stern holds an M.B.A. from NYU's Stern School of Business and a B.A. from Franklin & Marshall College. Mr. Stern specializes in M&A for all types of physician practices. He closed the sale of The Waldorf Center for Plastic Surgery in Portland, The Spa at the Waldorf Center in Seattle, and New Horizons Center for Cosmetic Surgery in Chicago and is working with numerous plastic surgery clinics, as well as medical spas.
Beth Zonerich
CEO
Pinnacle Fertility
With over 25 years of work experience in various leadership roles, I am a seasoned executive with a passion for strategy, business development, and innovation. I am currently the Chief Executive Officer at Pinnacle Fertility, a leading provider of fertility care in the US. My mission is to help more people achieve their dreams of parenthood by delivering high-quality, personalized, and compassionate care. I bring diverse perspectives and experiences to the team, having worked in different industries, markets, and functions. I value collaboration, integrity, and excellence, and I strive to create a culture that fosters these principles.
Prior to joining Pinnacle Fertility, I was the Co-Founder/CEO of Advanced Fertility Care, where I oversaw the operations and growth of three fertility offices. I successfully led the integration of the clinics into the InVitro Sciences network, implemented best practices and standards, and increased revenue and profitability. I also developed and executed strategic initiatives to expand the market share and enhance the patient experience. I leveraged my skills in strategy, budgeting, and business development to drive results and innovation.
